• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

In Vitro Metabolism

Evaluating the efficacy and safety of drugs through metabolic assays

Syngene is well-versed in conducting in vitro metabolic assays that help calculate the efficacy, dosage rate, and safety profile of a drug candidate through cytochrome P450 and non-P450 metabolic pathways. Our integrated and tiered approach uses liver microsomes, S9 fractions, and hepatocytes, in suspension and plated, to obtain accurate information on in vivo clearance mechanisms.

Through metabolic stability assays, we measure the in vitro clearance of compounds in liver microsomes and hepatocytes across different species. Our stability assays cover a diverse set of compounds, including low, moderate, and high-clearance compounds.

Our range of metabolic assays include:

  • Liver microsomes
  • Hepatocytes
  • S9 fractions
  • Cytosol
  • Enterocytes in both dogs and humans

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To download, Please share your details

To download, Please share your details